BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease
Search BioPortfolio:       

UCB S.A

UCB is a leading global biopharmaceutical company dedicated to the research, development and commercialisation of innovative pharmaceutical and biotechnology products in the fields of central nervous system disorders, allergy/respiratory diseases, immune and inflammatory disorders and oncology - UCB focuses on securing a leading position in severe disease categories.VisionTo build a global biopharmaceutical leader, based on unique blending of innovation, entrepreneurship and proven experience bringing to specialists first, new medicines to treat patients suffering from severe diseases.ValuesPassion and PerformanceWe are passionate about what we do and about UCB's performance.


Contact Details:
Allée de la Recherche, 60
Brussels
1070
Belgium
Tel:32/2/559.99.99
Fax:32/2/559.99.00
Email:contactucb@UCB-Group.com
WWW:

www.ucb-group.com/




Recent Publications by UCB S.A:

Visualization of SV2A conformations in situ by the use of Protein Tomography.
The synaptic vesicle protein 2A (SV2A), the brain-binding site of the...
12th August, 2008
Department of Molecular and Cellular Sciences, UCB S.A., Granta Park, Biochem Biophys Res Commun. 2008 Aug 7.
DOI Direct Link
2,6-Quinolinyl derivatives as potent VLA-4 antagonists.
A new series of 2,6-quinolinyl derivatives was prepared leading to potent...
25th April, 2007
UCB S.A., R&D, Chemin du Foriest, B-1420 Braine-l'Alleud, Belgium. Bioorg Med Chem Lett. 2007 Jan 1;17(1):142-6. Epub 2006 Oct 10.
DOI Direct Link
Arylsulfonamides as a new class of cannabinoid CB1 receptor ligands: identification of a lead and initial SAR studies.
High-throughput screening of the UCB sample collection identified the...
25th April, 2007
CNS Molecular and Cellular Biology, Centre for CNS Innovation, UCB S.A., Bioorg Med Chem Lett. 2007 Jan 1;17(1):272-7. Epub 2006 Oct 5.
DOI Direct Link
The connexin 36 blockers quinine, quinidine and mefloquine inhibit cortical spreading depression in a rat neocortical slice model in vitro.
A protocol for inducing cortical spreading depression (SD) on rat...
3rd February, 2007
UCB S.A., CNS Research, B-1420 Braine-l'Alleud, Belgium. Brain Res Bull. 2006 Dec 11;71(1-3):23-8. Epub 2006 Aug 11.
DOI Direct Link
Binding characteristics of levetiracetam to synaptic vesicle protein 2A (SV2A) in human brain and in CHO cells expressing the human recombinant protein.
A specific binding site for the antiepileptic drug levetiracetam...
26th July, 2006
UCB S.A., CNS Research, Chemin du Foriest, 1420 Braine L'Alleud, Belgium. Eur J Pharmacol. 2006 Apr 24;536(1-2):102-8. Epub 2006 Mar 10.
DOI Direct Link

View more UCB S.A research publications.

BioNews Results for UCB S.A:

BIO 2008 Aftermath: Biotech Heading For $100 Billion Annual Business
Midwest Business:  Jul 31 2008 12:44AM Matching: ucb s
DIARY - Western European Corporate events from July 30, 2008
Forbes.com:  Jul 31 2008 6:10AM Matching: ucb s
DIARY - Western European Corporate events from July 30, 2008
Interactive Investor International:  Jul 31 2008 5:05AM Matching: ucb s
Sanofi-Aventis: Second-Quarter 2008 Results
Pharmalive.com:  Jul 31 2008 8:20PM Matching: ucb s
DIARY - Western European Corporate events from July 31, 2008
Forbes.com:  Jul 31 2008 9:13AM Matching: ucb s
Promote your company here: BioNewsCast - Press Release Distribution

View more UCB S.A news.

UCB S.A Patents:

US Patent No.Title
6384115 Plasticized polymer compositions
6471970 Use of pharmaceutical compositions capable of being gelled in periodontology
6489329 Pharmaceutical compositions for the treatment of rhinitis
6524804 Process for determining antibiotics containing a .beta.-lactam ring in a biological fluid
6624218 Plasticized polymer compositions

View more UCB S.A patents.

BioPortfolio Ltd provides targeted e-mail address lists for the life science sector - we can enable you to contact around 16 individuals from UCB S.A using this service.

Contact BioPortfolio for a quote for a customised Excel verision of BioCorporate or BioEmail databases.

This page has been viewed 145 times since April 2007, the link to the organisation's website has been followed 23 times

Search for more companies in Brussels

Search for more companies in



This site uses Thumbshots previews, resources from the NCBI applied. Maps are centred on zip/postcodes and should not be relied upon for exact building locations. Some information on this page has been collected automatically and may not have been verified.
BioPortfolio search results for UCB S.A
 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.  See User Agreement

Send comments and feedback to:
Peter Barfoot Managing Director, BioPortfolio Ltd.
UK Tel: (+44) 1300 321501
USA Voicemail and Fax: (+1) 415 680 2472

All rights reserved. All other trademarks recognized.

BioPortfolio Limited is registered in England & Wales at Wessex Barn, Dorchester Road, Frampton, Dorset, DT2 9NB, UK. No.3312883 VAT No. GB 744 6483 10

Copyright 1997-2008 - BioPortfolio Limited.